InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2020-08-27 | Susie Lee(D-NV03) | house | Sale | $1,001 - $15,000 |
| 2020-02-24 | Susie Lee(D-NV03) | house | Purchase | $1,001 - $15,000 |
| 2020-01-06 | Susie Lee(D-NV03) | house | Purchase | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenues | $110.0M+2.8% | $107.0M+13.8% | $94.0M-5.1% | $99.0M-6.6% | $106.0M |
| Revenues | $110.0M+2.8% | $107.0M+13.8% | $94.0M-5.1% | $99.0M-6.6% | $106.0M |
| Selling, general and administrative | $3.44B+4.3% | $3.30B+13.0% | $2.92B+11.1% | $2.63B+0.0% | $2.62B |
| Research and development | $629.0M+2.1% | $616.0M+2.0% | $604.0M+14.2% | $529.0M+13.8% | $465.0M |
| Amortization of intangible assets | $1.00B-7.1% | $1.08B+0.0% | $1.08B-11.4% | $1.22B-11.6% | $1.38B |
| Goodwill impairments | $145.0M | $0-100.0% | $493.0M-40.2% | $824.0M+75.7% | $469.0M |
| Asset impairments | $8.0M-72.4% | $29.0M-46.3% | $54.0M+260.0% | $15.0M | — |
| Restructuring, integration and separation costs | $77.0M+140.6% | $32.0M-48.4% | $62.0M | — | — |
| Other expense, net | $142.0M-42.5% | $247.0M+782.1% | $28.0M-20.0% | $35.0M-90.6% | $373.0M |
| Total expenses | $8.45B+4.6% | $8.08B+3.7% | $7.79B+1.6% | $7.67B | — |
| Operating income | $1.81B+17.3% | $1.55B+60.5% | $963.0M+112.1% | $454.0M+0.9% | $450.0M |
| Interest income | $48.0M+45.5% | $33.0M+26.9% | $26.0M+85.7% | $14.0M+100.0% | $7.0M |
| Interest expense | -$1.60B-15.6% | -$1.39B-4.5% | -$1.33B+9.3% | -$1.46B-2.7% | -$1.43B |
| Gain on extinguishment of debt | $162.0M+604.3% | $23.0M+2200.0% | $1.0M-99.9% | $875.0M | — |
| Foreign exchange and other | -$52.0M-10.6% | -$47.0M+9.6% | -$52.0M-550.0% | -$8.0M-214.3% | $7.0M |
| Income (loss) before income taxes | $367.0M+119.8% | $167.0M+142.8% | -$390.0M-202.3% | -$129.0M | — |
| Provision for income taxes | -$247.0M-3.3% | -$239.0M-8.1% | -$221.0M-166.3% | -$83.0M | — |
| Net income (loss) | $120.0M+266.7% | -$72.0M+88.2% | -$611.0M | — | — |
| Net loss attributable to noncontrolling interest | $37.0M+42.3% | $26.0M+36.8% | $19.0M | — | — |
| Net income (loss) attributable to Bausch Health Companies Inc. | $157.0M+441.3% | -$46.0M+92.2% | -$592.0M | — | — |
| Basic (in dollars per share) | $420K+423.1% | -$130K+92.0% | -$1.6M | — | — |
| Diluted (in dollars per share) | $420K+423.1% | -$130K+92.0% | -$1.6M | — | — |
| Basic (in shares) | $370.9M+0.8% | $368.0M+0.8% | $364.9M | — | — |
| Diluted (in shares) | $375.0M+1.9% | $368.0M+0.8% | $364.9M | — | — |
| Product sales | |||||
| Revenues | $110.0M+2.8% | $107.0M+13.8% | $94.0M-5.1% | $99.0M-6.6% | $106.0M |
| Revenues | $110.0M+2.8% | $107.0M+13.8% | $94.0M-5.1% | $99.0M-6.6% | $106.0M |
| Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues | $64.0M+20.8% | $53.0M+32.5% | $40.0M-16.7% | $48.0M+9.1% | $44.0M |
| Other revenues | |||||
| Revenues | $110.0M+2.8% | $107.0M+13.8% | $94.0M-5.1% | $99.0M-6.6% | $106.0M |
| Revenues | $110.0M+2.8% | $107.0M+13.8% | $94.0M-5.1% | $99.0M-6.6% | $106.0M |
| Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues | $64.0M+20.8% | $53.0M+32.5% | $40.0M-16.7% | $48.0M+9.1% | $44.0M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Why Bausch Health Companies Was Crawling Higher This Week
TSX up 455 Points at Midday With Healthcare, Materials, The Best Performers
BHC Q1 Earnings Miss Estimates, Sales Grow on Salix & Solta Strength
Bausch Health Companies Inc (BHC) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...